Doctor vaccinating the patient

UK Approve Pfizer/BioNTech vaccine- Safe to Use

The Pfizer/BioNTech vaccine is ready to distribute and approved by the UK government. The UK is the first country in the world who closed the deal of Pfizer vaccine.

The UK declared the vaccine as safe to use, as they are on the way to mass vaccination. In the previous article, we did a complete analysis of the vaccine and the result driven by trial data.

MHRA, which is the medicines regulator in the UK, expresses his views about the Pfizer/BioNTech covid vaccine. He said that the vaccine offers up-to 95% effectiveness against Covid-19 & is safe to mount. According to the officials of Pfizer, the Initial batch of dosses are on the way towards the UK. And we will be sending more doses soon.

NHS (The government department of national health service) will communicate with peoples said, the Health secretary.

Distribution Process

In the first phase, the peoples from the health care frontline and the Elderly are our top priority. The reason behind this is in health sectors like hospitals the facility to store the vaccine is already exists. It really meets the requirement of the vaccine to be stored at a temperature of -70C. Those vaccines will be likely used for NHS staff and patients etc. This is the way we can make it possible to not waste any vaccine at any cost.

To achieve the target of 20 million peoples being vaccinated successfully, The UK ordered 40 million doses. According to Mr. Hancock, the process of reaching the vaccine will be completed by the end of December this year 2020. Which is already in the process hopefully will be available for the next week.

The vaccines will be sent to health care sectors with have temperature facilities to store. That implies sending it out to mind homes, where there might be a couple of dozen occupants in certain spots, would prompt an immense measure of immunization being squandered.

3 Replies to “UK Approve Pfizer/BioNTech vaccine- Safe to Use”

Leave a Reply

Your email address will not be published. Required fields are marked *